ITMCTR2000004206招募中未知
Capital health development research project
Dongfang Hospital Affiliated to Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1. Patients who met the diagnostic criteria of AMI were successfully treated with PCI and revascularization;
- •2. At least one of the diagnostic criteria of ischemia-reperfusion injury was met;
- •(1) The symptoms of myocardial ischemia worsened or myocardial infarction occurred again after opening the occluded vessel during PCI and revascularization;
- •(2) Coronary angiography showed slow flow, no reflow, small branch occlusion, TIMI <= 2, or complicated with thrombosis, dissection or spasm;
- •(3) Atrial and ventricular arrhythmias, bradycardia, delayed ST segment depression and new ST segment elevation were found in ECG;
- •(4) Decreased diastolic function or new wall motion abnormalities detected by echocardiography;
- •(5) Myocardial radionuclide perfusion imaging revealed new viable myocardium loss or abnormal wall motion.
- •3. Patients with Qi deficiency and blood stasis syndrome in TCM;
- •4. Patients aged 18-80 years old;
- •5. Patients who voluntarily participate and sign informed consent.
排除标准
- •1. Patients with acute complications of PCI (malignant arrhythmias such as cardiogenic shock and ventricular fibrillation after cardiopulmonary resuscitation, valve prolapse caused by rupture of chordae tendineae / papillary muscle, heart rupture, coronary artery perforation, pericardial tamponade, continuous IABP assistance for cardiogenic shock, continuous pacemaker assistance for severe bradycardia, continuous heart failure that cannot be relieved by drugs, etc.);
- •2. Patients with refractory hypertension, systolic blood pressure >= 180mmhg or diastolic blood pressure >= 110mmhg;
- •3. Severe liver dysfunction (alanine aminotransferase >= 1.5 times normal), renal dysfunction (serum creatinine >= 194.5 umol / L), serum potassium level >= 5.5 mmol / L, primary disease of blood system, malignant tumor, severe complications of diabetes mellitus, hyperthyroidism, hypothyroidism and other serious secretory diseases;
- •4. Patients with severe consumption or malignant tumor;
- •5. Patients with new cerebral hemorrhage within 6 months;
- •6. Patients with bleeding, trauma or active peptic ulcer within one month;
- •7. Suspected or definite allergy to the test drug;
- •8. Pregnant or lactating women or objects with pregnancy plans;
- •9. Patients with mental diseases and infectious diseases;
- •10. Subjects who participated in other clinical studies in recent one month;
- •11. Subjects who have used any traditional Chinese medicine and proprietary Chinese medicine preparations in recent 4 weeks.
研究者
相似试验
尚未招募
1 期
Clinical study on TCM Comprehensive intervention program and curative effect evaluation of chronic heart failure based on Yiqi Huoxue Lishui methodChronic heart failureITMCTR2000004176Dongfang Hospital Affiliated to Beijing University of Chinese Medicine
招募中
1 期
Clinical efficacy and safety of Chaixiong Qiwei formula for Tension-type HeadacheITMCTR2100004307Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences
已完成
不适用
Examining the Efficacy of the Health Project, the Walking (Exercise) Course for YouJPRN-UMIN000043799iigata University24
尚未招募
不适用
trecht Health Project - Utrecht Cardiovascular Cohort (UHP-UCC)100192801002914910003216atherosclerosiscardiovascular diseaseNL-OMON55070niversitair Medisch Centrum Utrecht800
已完成
不适用
Study to evaluate health care situation and quality of life in patients with registered anti-VEGF treatment in neovascular AMD, diabetic macular edema or retinal vein occlusioPatients with neovascular AMD or visual impairment due to diabetic macular edema or visual impairment due to retinal vein occlusion.H34.8H35.3H35.8Other retinal vascular occlusionsDegeneration of macula and posterior poleOther specified retinal disordersDRKS00010267ovartis Pharma GmbH3,224